SMTL ID : 9aqz.1

Crystal structure of Bcl-xL in complex with a small molecule inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

monomer

Ligands

1 x 01: (3M)-3-(1-{[(1r,3R,5S,7r)-adamantan-1-yl]methyl}-5-methyl-1H-pyrazol-4-yl)-6-{8-[(1,3-benzothiazol-2-yl)carbamoyl]-3,4-dihydroisoquinolin-2(1H)-yl}pyridine-2-carboxylic acid

01.1: 21 residues within 4Å: Chain A: E.46, F.47, Y.51, R.52, F.55, S.56, D.57, L.58, T.59, E.79, L.80, N.86, G.88, R.89, V.91, A.92, S.95, F.96, A.99, Y.145 Ligands: CD.3 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:E.46, A:Y.51, A:Y.51, A:F.55, A:F.55, A:L.58, A:T.59, A:L.80, A:R.89, A:V.91, A:A.92, A:A.99, A:Y.145 Hydrogen bonds: A:S.56, A:L.58, A:N.86 Water bridges: A:G.88 Salt bridges: A:R.89 pi-Stacking: A:F.55

2 x CD: CADMIUM ION(Non-covalent)

CD.2: 1 residues within 4Å: Chain A: E.42 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:E.42, A:E.42 CD.3: 2 residues within 4Å: Chain A: N.86 Ligands: 01.1 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Judd, A.S. et al., BCL-X L -targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors. Sci Adv (2024)

Release Date

2024-10-16

Peptides

Bcl-2-like protein 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bcl-2-like protein 1

Related Entries With Identical Sequence